galenica ag-reg (GALN:SIX Swiss Ex)
Head of Investor Relations, Director, Member of Audit & Risk Committee and Member of Swiss Healthcare Committee, Galenica Ltd.
|Age||Total Calculated Compensation||This person is connected to 13 board members in 3 different organizations across 4 different industries.|
See Board Relationships
Mr. Fritz Hirsbrunner serves as the Head of Investor Relations at Vifor Pharma Ltd. Mr. Hirsbrunner has been the President of Aspreva International Ltd., (formerly Aspreva Pharmaceuticals Corporation) since January 2008. He has been Head of Investor Relations at Galenica Ltd., since 2013. He served as the Chief Financial Officer, Deputy Chief Executive Officer and Head of the Finance & Corporate Services Division at Galenica Ltd. (also known as Galenica Holding Ag) until ...
Untermattweg 8Phone: 41 58 852 81 11
Bern, Bern 3027
Fax: 41 58 852 81 12
Board Members Memberships*
Member of The Board of Directors
President and Director
Head of Investor Relations, Director, Member of Audit & Risk Committee and Member of Swiss Healthcare Committee
Université de Lausanne
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|William K. Heiden||Chief Executive Officer, President and Director|
AMAG Pharmaceuticals, Inc.
|Robert L. Chioini||Founder, Chairman, Chief Executive Officer, President and Member of Stock Option Committee|
Rockwell Medical, Inc.
|Robert Maurice Powell Jr.||Chairman of the Management Board for Fresenius Medical Care Management AG and Chief Executive Officer of Fresenius Medical Care Management AG|
Fresenius Medical Care AG & Co. KGAA
|Liam M. FitzGerald||Chief Executive Officer, Director and Member of Nomination Committee|
UDG Healthcare plc
|€684.0K||Compensation as of Fiscal Year 2013.|